Autoimmunity in the era of immune checkpoint inhibitors: the evolving epidemiology of autoimmune diseases and the possible impact of COVID-19
2026 · Autoimmunity Reviews · 0 citations
https://doi.org/10.1016/j.autrev.2026.104002
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
17
Papers
132
Citations
6
h-index
4
i10-index
Abdulrahman Elsalti is an academic researcher from Istanbul Medipol University. The author has contributed to research in topics: Systemic Lupus Erythematosus Research & Cancer Immunotherapy and Biomarkers & T-cell and B-cell Immunology. The author has an h-index of 6, co-authored 15 publications.
ORCID: 0000-0002-4130-3978Click to start Chat